Allan Barger | Oct 10, 2004 | 1 min read
In your editorial launching of BioBusiness1 you rightly note the business potential of new discoveries in molecular and genetic biology. It sounds useful and I look forward to reading it. One thing I found missing in your article is a critical eye toward the role of business in science. With a current government administration twisting and suppressing scientific discoveries while simultaneously giving huge perks to pharmaceutical companies, it behooves all of us to pay close attention to who is